Grimes & Company Inc. Acquires New Stake in iShares Biotechnology ETF $IBB

Grimes & Company Inc. bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 18,163 shares of the financial services provider’s stock, valued at approximately $2,298,000.

Other large investors have also modified their holdings of the company. Moors & Cabot Inc. lifted its stake in shares of iShares Biotechnology ETF by 2.0% in the first quarter. Moors & Cabot Inc. now owns 29,053 shares of the financial services provider’s stock worth $3,716,000 after buying an additional 558 shares in the last quarter. IFP Advisors Inc raised its holdings in iShares Biotechnology ETF by 23.9% in the 1st quarter. IFP Advisors Inc now owns 19,849 shares of the financial services provider’s stock valued at $2,539,000 after acquiring an additional 3,831 shares during the last quarter. N.E.W. Advisory Services LLC acquired a new stake in iShares Biotechnology ETF in the 1st quarter valued at about $45,000. Kingswood Wealth Advisors LLC lifted its stake in iShares Biotechnology ETF by 81.2% in the 1st quarter. Kingswood Wealth Advisors LLC now owns 4,532 shares of the financial services provider’s stock worth $570,000 after purchasing an additional 2,031 shares in the last quarter. Finally, John G Ullman & Associates Inc. purchased a new stake in iShares Biotechnology ETF in the 1st quarter valued at $230,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB opened at $150.52 on Tuesday. The firm has a 50-day moving average price of $139.51 and a 200 day moving average price of $130.07. iShares Biotechnology ETF has a 12-month low of $107.43 and a 12-month high of $151.79.

iShares Biotechnology ETF Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Tuesday, September 16th were issued a $0.0828 dividend. The ex-dividend date was Tuesday, September 16th. This represents a $0.33 dividend on an annualized basis and a yield of 0.2%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.